The value of iron treatment for postoperative obstetric patients with anemia: a randomized double blind controlled trial
Completed
- Conditions
- anemiairon-poor blood10002086
- Registration Number
- NL-OMON44876
- Lead Sponsor
- Medisch Universitair Ziekenhuis Maastricht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 180
Inclusion Criteria
Inclusion Criteria;The patient has undergone a primary caesarean section;The postoperative hemoglobin is between 5-7 mmol / L
Exclusion Criteria
Exclusion Criteria;• Malignancy during pregnancy or during the first six weeks postpartum
• HELLP syndrome
• Pre-eclampsia
• Infections
• Bloodtransfusions during pregnancy or peri-or postoperative
• Hematologic disorder (hemoglobinopathy; hemochromatosis)
• Erythropoiesis-stimulating agents < 3months ago
• Myelosuppressive therapy in history
• Hepatitis
• HIV
• Alcohol abuses
• Not understanding Dutch
• Previous allergic reaction to oral or intravenous iron
• Incapability
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>primary:<br /><br>• Hemoglobin levels after 3 and 6 weeks</p><br>
- Secondary Outcome Measures
Name Time Method <p>secondary:<br /><br>• Quality of life after 1, 3 and 6 weeks<br /><br>• Side effects of the medication<br /><br>• Predictive value of other parameters such as CRP, transferrin, ferritin and<br /><br>hepcidin<br /><br>• Cost-benefit analysis</p><br>